BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Dopamine KnewtonCR

Expert replies
by bvn » Fri Dec 03, 2010 2:01 am
Dopamine is a hormone and neurotransmitter that plays a pivotal role in providing a sense of pleasure in order to reward the brain and reinforce certain behaviors. However, a serious concern of neuropsychologists is that, in some people, traumatic situations can release excessive levels of dopamine in the brain, which can potentially lead to behavioral disorders such as psychoses and schizophrenia.

Which of the following, if true, points to the most serious flaw of a plan to develop an antipsychotic medication that would block the brain from experiencing the effects of dopamine?


(A) Such a medication would indiscriminately block dopamine, whether it is activated by situations that are rewarding or traumatic. correct

(B) Such a medication will not be available for many years due to the lengthy testing and approval process.

(C) Scientists have not yet discovered why these levels of dopamine are released in some people, and not in others.

(D) Such a medication will reduce a person's risk of developing psychoses but will not protect that person from developing schizophrenia. your answer

(E) This medicine will have no discernible effect on people for whom dopamine is not naturally released by rewarding situations.
Join the discussion
Source: — Critical Reasoning |

by shovan85 » Fri Dec 03, 2010 3:12 am
bvn wrote:Dopamine is a hormone and neurotransmitter that plays a pivotal role in providing a sense of pleasure in order to reward the brain and reinforce certain behaviors. However, a serious concern of neuropsychologists is that, in some people, traumatic situations can release excessive levels of dopamine in the brain, which can potentially lead to behavioral disorders such as psychoses and schizophrenia.

Which of the following, if true, points to the most serious flaw of a plan to develop an antipsychotic medication that would block the brain from experiencing the effects of dopamine?
See the Red highlighted sentences and especially the Bold part. You can see that by implementing the plan the flow of Dopamine is blocked. So, this will stop one of the pivotal roles of the Brain. Clearly, the plan is flawed. If it would have used the word regulated rather than blocked then it would have been correct.

Thus Only A says so.

(A) Such a medication would indiscriminately block dopamine, whether it is activated by situations that are rewarding or traumatic.
If the problem is Easy Respect it, if the problem is tough Attack it
Join the discussion

by diebeatsthegmat » Fri Dec 03, 2010 5:49 am
bvn wrote:Dopamine is a hormone and neurotransmitter that plays a pivotal role in providing a sense of pleasure in order to reward the brain and reinforce certain behaviors. However, a serious concern of neuropsychologists is that, in some people, traumatic situations can release excessive levels of dopamine in the brain, which can potentially lead to behavioral disorders such as psychoses and schizophrenia.

Which of the following, if true, points to the most serious flaw of a plan to develop an antipsychotic medication that would block the brain from experiencing the effects of dopamine?


(A) Such a medication would indiscriminately block dopamine, whether it is activated by situations that are rewarding or traumatic. correct

(B) Such a medication will not be available for many years due to the lengthy testing and approval process.

(C) Scientists have not yet discovered why these levels of dopamine are released in some people, and not in others.

(D) Such a medication will reduce a person's risk of developing psychoses but will not protect that person from developing schizophrenia. your answer

(E) This medicine will have no discernible effect on people for whom dopamine is not naturally released by rewarding situations.
please dont post the answer before discusing, and if you want to post the answer, please spoil it!
Join the discussion